Internal Medicine, Hematology · Kyle, TX
NPI
1649487570
Since 2007
Specialty
Internal Medicine, Hematology
Code 207RH0000X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
1180 Seton Pkwy Ste 150
Kyle, TX, 78640
Phone (512) 574-6530
Groups this clinician bills Medicare through
Medicare paid, 2024
$24K
242 services
Medicare patients, 2024
90
Average age 69
Drug cost, 2024
$2.8M
628 prescriptions
Company payments, 2025
$1,233
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Boone W Goodgame was code 99215 (office e&m - established), 134 times for 44 patients. In total Boone W Goodgame billed 242 services in 10 codes, and Medicare paid $24K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-03-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 134 | 44 | $103.12 | $14K |
| 99214 Office E&M - Established | Facility | 37 | 28 | $67.97 | $2,515 |
| 99233 Hospital E&M - Subsequent | Facility | 27 | 14 | $91.99 | $2,484 |
| 99223 Hospital E&M - Initial | Facility | 20 | 19 | $127.81 | $2,556 |
| 99205 Office E&M - New | Facility | 13 | 13 | $131.56 | $1,710 |
By year: 2022 $21K for 225 services; 2023 $30K for 302 services; 2024 $24K for 242 services.
Medicare prescription drug claims, 2024
In 2024, the drug Boone W Goodgame prescribed most often to Medicare patients was Abiraterone Acetate, with 52 prescriptions and refills. In total Boone W Goodgame wrote 628 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Abiraterone Acetate Generic | 52 | 52 | Under 11 | $71K |
| Jakafi Ruxolitinib Phosphate | 44 | 44 | Under 11 | $820K |
| Prochlorperazine Maleate Generic | 42 | 42 | 20 | $578 |
| Ondansetron Hcl Generic | 36 | 36 | 18 | $334 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 29 | 29 | Under 11 | $876 |
| Dexamethasone Generic | 28 | 32 | 12 | $546 |
| Prednisone Generic | 28 | 43 | Under 11 | $157 |
| Valacyclovir Valacyclovir Hcl | 23 | 25 | Under 11 | $807 |
| Hydroxyurea Generic | 21 | 33 | Under 11 | $647 |
| Lenalidomide Generic | 17 | 17 | Under 11 | $237K |
| Eliquis Apixaban | 16 | 16 | Under 11 | $9,434 |
| Erleada Apalutamide | 15 | 15 | Under 11 | $258K |
| Xtandi Enzalutamide | 13 | 13 | Under 11 | $179K |
| Revlimid Lenalidomide | 13 | 13 | Under 11 | $224K |
| Cotellic Cobimetinib Fumarate | 13 | 13 | Under 11 | $96K |
Brand drugs: 175 claims; generic drugs: 453 claims; opioid claims: 66.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Boone W Goodgame $1,233 ($12.42 in general payments such as food, travel and fees and $1,220 for research) from 4 companies. The largest payer was F. Hoffmann-La Roche AG with $1,147.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.